Scott Kahan, an obesity medicine specialist and Director of the National Center for Weight and Wellness, May 7, 2025 Interview with Dr
Bottom line: CagriSema could become the go-to option for patients who want more than Ozempic alone can offer, especially those struggling with fatty liver disease or stubborn appetite control
While nausea typically resolved over time, diarrhea (observed in 5% of our cohort) tended to persist when present, though it was manageable in most cases with antidiarrheal agents
Microdosing is considered safe when done under medical supervision
After week 9, the dosage can be raised to 7.5 mg a week, if needed for additional glucose control
Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass